Well, I'm still here. Can't even remember how many units I was in.

....people here still fighting.

Well, I'm still holding onto my 55k units.

*7 mil

So the global lockdown continued to make trouble for Q2 report in EMS electronics sector...but by Q3 I believe the supply and demand would have recovered substantially.
And they have license to manufacture but not yet approval to market.
If it drops a lot tomorrow I might average down. But who knows...XOX loss increased by 7k but share price still jumped after QR. Don't know what retailers are thinking sometimes.

In any case, I am quite certain there will at least be a drop between 9am-9.30am tomorrow.

@Mgn315
Are you referring to Q1? Because Q2 is not out yet.
Q1 reduction in profit was because of the global lockdown interrupting supply and demand chain, thus adversely affecting electronic segment of EMS.
It wasn't because they had "too much on their plate".

Price movement before QR announcement does not always indicate if QR is good or bad.
I wouldn't even say it is a good indicator.
Can observe from XOX today. Price went up constantly for the past 5 days approaching QR but now...?

It would be hypocrite of me to say that some people are wrong to speculate bad things about K1 because 3 months back I said nothing when people speculate only good things about K1.

But.
If right now you are badmouthing this counter even though in the past you have promoted it, or said or implied that anything over 50c is a reasonable buy, then you are doing no favors to those who followed your advice that time and held their share ever since.

Also, spamming video links is not providing facts. It is spam.

What're you waiting for?
Sell! Then I can sapu at the lowest price possible to enjoy next year's rebound.

@huatkopi88
Alright, I admit whether it was a good close or not is depending on who's perspective.
But my point was that you sometimes state the outcome when the outcome has not happened, especially regarding the QR.

@huatkopi88
I'm not saying K1 doesn't have issues...but I'm a bit perplexed by your comments.
Yesterday before K1 even close you already said "weak close". In the end it close at 50.5c which is not bad.
Today QR is not out yet but you already say "QR no noticeable impact". It may not even be out until the end of the month...why already making assumption?

@silverwave
I think it's just the glove resurgence.

Just checked in for the 2nd time today...absolutely unpredictable movement.
I hope everyone gets something out of this.

I'm not seeing the point of stepping on people who make a mistake.

@Mgn315
The lack of updates is concerning...but it is easy to identify at least one of the reasons for red this time. When gloves can lose over RM2, fallout is expected.

I would think to wait first...remember that time when some US company said "we got successful trials" few months ago? Then everyone realised it was a long way to go.
I feel this is the initial shock. Then tonight, we will see which country leader is willing to accept the vaccine for their people. I would at first assume Trump and his allies would not be among those accepting it, but then again he needs some victory over the virus before November election.

Opening slightly red lol.
Same as some of the other healthcare counters.
Probably bought Russia's vaccine story.

I hope some who bought over 50 sen months ago have profited from the boom earlier.
You deserve something after holding for so long.
Because of how K1 management has kept us in the dark for almost 2 months, it allows room for uncertainty, thus volatility, to occur.
Next time it booms, maybe sell a part of it.
Some bought at very low price; they should be safe. But if you bought in at high price, my personal opinion is to exercise caution.

For disclosure, my current holding is 50k units at 49sen.

I do not know who are the players here, but right now from my perspective the price is being driven by momentum of the entire healthcare sector. When even Karex can jump like this, I perceive it as positive sentiment applied to all Covid-related counters.

From my perspective, the driving force is at risk because the price is not being propelled by either updates or earnings. When sentiment shifts and K1 has no development, it is a possibility that all healthcare counters will take a hit.

Of course, I am no fortune-teller. I hope you guys who bought high months ago can enjoy good profit.

@smallkid91
Can I see where you got the source for those generation figures.
I don't hold TNB but I want to see that info so I can enter at some point.

I just want to disclose that today I took some profit and reduced my holding to 40k units.
Partly because I want to take profit and partly because the management haven't updated about nasal swab for 1.5 months.
Yes, I know I'm bilis but I have recommended this counter before so I should disclose.

@RotiTelur
Not sure who you mean by 'you guys'.
If you mean oilwaterman and mudzaffar, they've always provided a balancing force to the positive sentiment.
Otherwise, I don't think much has changed...contra players will panic, long-term holders will sit back, and the rest will hope for tomorrow.

As for me, I'm expecting something before Aug 17 when Singapore-Malaysia border reopens...something to show they've been making progress in the absence of nasal swab updates for the past 1.5 months.

Top 3 traded stock in Bursa...that is impressive.
I might take some profit if it breaks 53c.

Not much can be done. Healthcare sector down today, or at least for the time being.
Dow Jones red.

Today, glove counters all green especially Topglove, Carepls, and Comfort.
Majority of healthcare counters up and by no small amount either. See HLT, LKL, Luxchem, RGTbhd. Even Karex also up.

Do you believe K1 uptrend is because of healthcare momentum or because there is news coming?
Personally, I don't know..but if this momentum keeps up we could have a bullish MACD cross.

@nuilam hali
Well, good to have differing opinions.
But there's also this: IBM beats estimates; sees gains as customers accelerate shift to cloud - Reuters article dated 21/7/2020

"Revenue from the cloud business, previously headed by Krishna, rose 30% to $6.3 billion in the second quarter."

@silverwave
The explanation you can see from investor39's comment history.
For the info source of RM0.32 share option, you can see at https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3052590

Ok, just topped up 25k units @ 3.90.
If anyone topping up be careful ya. Not sure what is driving it up.

Someone or something is making big buy-ins right now.

@TOPinvester
K1's EMS is 90% export-business.

"The EMS business is export driven, on average with more than 90% of its business each year since its inception in 2001, exported primarily to Europe, US and various countries in Asia." (Annual Report 2019, pg. 12)

@AMG2020
I'm happy to see that, but what are the chances of that being part of pilot manufacturing batch?
MoH approval is the main question atm.

Wah lao that spike. Wonder who just entered?

If today closes green, it would form the three white soldiers, correct?

@oilwaterman
Hexza -1 sen
Nylex -1.5 sen
PresBhd -2 sen
Rgtbhd -0.5 sen

But to be fair, some of those had already moved upwards some time back.

If no other news arrive, the performance in Q2 report will influence further movement.

@noob84
If I had more spare money I might. But this is all I'm willing to invest now for this counter. 95k is the most I've ever bought in a counter.

It is understandable for those caught at 0.50 or 0.40 to feel disappointed. I too wish I had taken profit when in green. But that's how it is...if we knew which direction it would go tomorrow, we wouldn't be here discussing.We're not sharks...not syndicates...we just do our research and hope that we are right. And I believe I'm right.

If you are scared to hold because you don't think it will be up by the end of this year, then cut loss may be good. For it to go to this price, I did not expect it either.

But if you can hold to the end of this year, I think it should be okay.
I might be bilis, but I'm not selling my 95k units because I like their business and liquidity.

@iloveking88
Besides a one-sentence mention from Reuters, not a single news article, even from Malaysia, was written about the pilot manufacturing, or TT Biotech, or CEO Martin's nice picture with Adham Baba.

I noticed that in nearly every single glove counter today, the moment the second session of market began, Carepls/Comfort/Kossan/Supermax/Harta/Topglove suddenly fell marginally.
This small slump dampened momentum for some healthcare counters, which you can see in LKL, HLT, Luxchem where it resulted in a mild downtrend until market close.

NASDAQ up does not mean K1 is up.
You can compare the two charts for the past two months. They do not necessarily move in the same direction.
Again, it's possibly due to people not knowing what is K1's normal business.

@oilwaterman
An explanation from management? Perhaps. Maybe. I'd like one too. I watched my 15k green become 3k red.

But since you asked me to explain earlier, my answer remains that it doesn't draw as much attention as other counters, and doesn't seem overly concerned about drawing attention either.

We know that K1's "medical/healthcare segment of the EMS business was exempted from the
Movement Control Order (MCO) which came into force on 18 March 2020" (QR12020, pg. 15).

If you plan to hold this counter until Q2 report is out, the main questions to ask are:

1. How much revenue from production of existing medical devices?
2. How did the pandemic affect cloud business and the demand for cloud?
3. How would electronics segment fare in terms of demand and supply?

@oilwaterman
The reasons most apparent to me are:

Glove counters have a ridiculous P/E. But their Covid-related biz is based on product lines already being produced. It is easier to numerically draw an estimate on future potential based on past results.
In K1, the revenue generated from its pandemic-related products has not been determined. So investors here are going into new territory.
(Though the earnings for cloud can be projected and I have calculated that it can substantially the lower P/E ratio).

But that begs the question as to how those other counters achieve a soaring share price despite not producing the pandemic related product yet?

As far as I know, K1 directors have not dumped their shares.
If that is true, then they are not playing the price-pumping game. They probably know that in long-term the company's value will show, so churning out sensational news like some other counters may not be their top priority.

K1's cash balance is good, unlike some other counters. But you would not readily expect contra players to read balance sheets. The trend now, after all, is "buy on rumour, sell when high."

In addition, it is quite possible that many traders do not know K1's business besides ventilators.

@MsBillionaire
If you're a billionaire it shouldn't matter.
But it depends how much you bought.
If you're looking to profit in the very near future, then you may want to cut and run as there are other counters that attract more contra players and syndicates.

The past QR quoted the China supply issue as one of the causes for loss in the EMS sector, so it can be volatile and not achieving its full potential in the short-run unless the ventilator/nasal swab biz begins, as it supposed to begin in this quarter. They did start manufacturing medical PPE in March 2020 (and much of their EMS segment has already been in healthcare), so it will be seen in Q2 report as to how well it supported earnings.

However, the Cloud sector should hold up quite well in this Covid time. But the benefits of acquiring the remaining 40% of G-AsiaPacific will only mainfest in Q3.

My own perspective is that in terms of potential and biz. segment diversity, this is a good investment. Personally, if you can hold, I think this is a bad time to sell.

@wickedlion
Likely long-term investment. Although I would think that Q2 will result in a short-term drop for most of these companies. I plan to pick up MBMR and UMW during that time.

Go ahead and cut loss if you cannot wait medium or long term.

Just my personal thoughts...the rebound at Topglove is beyond expectation.
I do not know how steady the price is at its current state and if investors decide to run soon, it may trigger another panic sell.
I do not know the future either, but I am worried as to what sustains the buying force at Topglove.

@Harley Dav
No offense, but you once also said regarding QR1 2020 that your insider friend told you that "their latest qr is making losses".

@TOPinvestor
I would just like to add that acquisition of cloud company finished at the end of Q2 so to see the 100% profit from cloud, it will only be shown in Q3.

So US put detention order on Topglove product...who knows what the effect will be.
Been over a month since K1 last touched 0.395.
Will it continue?
Some part of me hopes that money can flow back to other healthcare counters because some like K1 are no even affected.

Tomorrow masuk paper. Front page.